Standout Papers
Citation Impact
Citing Papers
Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases
2012
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
2008 StandoutScience
A Novel Gene, erm (41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
2009
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
NK Cells Lyse T Regulatory Cells That Expand in Response to an Intracellular Pathogen
2008
Infections Due to Rapidly Growing Mycobacteria
2006
Oxygen toxicity causes cyclic damage by destabilizing specific Fe-S cluster-containing protein complexes
2023
Hypoxia and intra-complex genetic suppressors rescue complex I mutants by a shared mechanism
2024 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012
2015
Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages
2007
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Applications of Chitin and Chitosan for Biomaterials
1996
Delayed graft function in kidney transplantation
2004 Standout
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Ribosomal drug resistance in mycobacteria
1996
Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study
2013
Chemokines and leukocyte traffic
1998 StandoutNature
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
2010
Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV Era
2007
Cystic fibrosis
2016 Standout
AIDS-Related Mycobacterium kansasii Infection with Initial Resistance to Clarithromycin
1998
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
The Acute Respiratory Distress Syndrome
2000 Standout
Has Mortality from Acute Respiratory Distress Syndrome Decreased over Time?
2008
Mycobacterium abscessus
2014
A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease
2014
The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea
2014
Neutrophil Activation by Monomeric Interleukin-8
1994 Science
Aerosolized amikacin for treatment of pulmonary Mycobacterium aviuminfections: an observational case series
2007
Hypoxia and Inflammation
2011 Standout
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
2010
Molecular Mechanisms of Clarithromycin Resistance in Mycobacterium avium: Observation of Multiple 238 rDNA Mutations in a Clonal Population
1996
Drug-Induced Hepatotoxicity
2003 Standout
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
Spontaneous Pneumothorax
2000 Standout
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Serial CT Findings ofMycobacterium massiliensePulmonary Disease Compared withMycobacterium abscessusDisease after Treatment with Antibiotic Therapy
2012
The therapeutic approach to non-tuberculous mycobacterial infection of the lung
2010
The Science of Antibiotic Discovery
2020 Standout
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms.
1995
Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
2013
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 Standout
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury
2009
Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs
2011
Nontuberculous Mycobacteria, Zambia
2009
An Outbreak of Mycobacterial Furunculosis Associated with Footbaths at a Nail Salon
2002
The molecular basis of asbestos induced lung injury
1999
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
The role of free radicals in asbestos-induced diseases
1992
Interstitial Nephritis, Thrombocytopenia, Hepatitis, and Elevated Serum Amylase Levels in a Patient Receiving Clarithromycin Therapy
1999
Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection
2004
Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction
2006
Antibiotic Treatment of Mycobacterium abscessus Lung Disease
2009
Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in Korea
2006
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Anatomic Lung Resection for Nontuberculous Mycobacterial Disease
2008
The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD
2003
Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
2004
Idiopathic pulmonary fibrosis
2011 Standout
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
1996 StandoutNature
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
2003
Natural killer cells as an initial defense against pathogens
2006
Interleukin-8 and the chemokine family
1995
Prevalence of Gastroesophageal Reflux Disease in Patients With Nontuberculous Mycobacterial Lung Disease
2007
Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells.
1997
Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease
2016
Nosocomial Outbreak of Respiratory Tract Colonization with Mycobacterium fortuitum : Demonstration of the Usefulness of Pulsed-Field Gel Electrophoresis in an Epidemiologic Investigation
1991
Clinical Significance of the Differentiation Between Mycobacterium avium and Mycobacterium intracellulare in M avium Complex Lung Disease
2012
Chemokine receptors: multifaceted therapeutic targets
2002
Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro
1997
Cytokines in human lung fibrosis
1996
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome
1999
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Mycobacterium tuberculosis CDC1551 Induces a More Vigorous Host Response In Vivo and In Vitro, But Is Not More Virulent Than Other Clinical Isolates
1999
Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries
2012
Early Detection of Type III Procollagen Peptide in Acute Lung Injury
1997
A Novel Alveolar Type I Cell–Specific Biochemical Marker of Human Acute Lung Injury
2000
Acid-induced Lung Injury
1999
Interleukin-8 Release during Early Reperfusion Predicts Graft Function in Human Lung Transplantation
2002
Mycobacterium abscessus Infection in Cystic Fibrosis
2000
Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massiliense Infection and Inducible Resistance
2012
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Talc-induced Expression of C-C and C-X-C Chemokines and Intercellular Adhesion Molecule-1 in Mesothelial Cells
1998
Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study
2015
Nontuberculous Mycobacteria
2003
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
1994 Standout
Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010
2013
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Genetic Dissection of Immunity to Mycobacteria: The Human Model
2002
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis
2015
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
2012
Acute Respiratory Distress Syndrome
2012 Standout
Differential Antibiotic Susceptibility of Mycobacterium abscessus Variants in Biofilms and Macrophages Compared to That of Planktonic Bacteria
2008
NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis
2006
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease
1995
The macrolides
2002
High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome
1993
PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria
1995
Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense , and Mycobacterium bolletii
2009
Drosophila RNAi Screen Reveals CD36 Family Member Required for Mycobacterial Infection
2005 Science
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Comparison of Methods for Identification of Mycobacterium abscessus and M. chelonae Isolates
2001
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy.
2001
Pseudo-outbreak of septicemia due to rapidly growing mycobacteria associated with extrinsic contamination of culture supplement
1997
MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence
2003 StandoutNobel
Radiographic and CT Findings of Nontuberculous Mycobacterial Pulmonary Infection Caused by Mycobacterium abscessus
2003
Frondosins, five new sesquiterpene hydroquinone derivatives with novel skeletons from the sponge Dysidea frondosa: Inhibitors of interleukin-8 receptors
1997
rpoB -Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria
2003 Standout
Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria
2002
Surgical Treatment of Pulmonary Diseases Due to Nontuberculous Mycobacteria
2008
Thin-Section CT Findings of Nontuberculous Mycobacterial Pulmonary Diseases: Comparison Between Mycobacterium avium-intracellulare Complex and Mycobacterium abscessus Infection
2005
Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype
2006
Infections due to non-tuberculous mycobacteria (NTM).
2004
The Host Defense of Drosophila melanogaster
2007 StandoutNobel
Pneumonectomy for nontuberculous mycobacterial infections
2004
The NKp46 Receptor Contributes to NK Cell Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium
2002
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
The Acute Respiratory Distress Syndrome
1996 Standout
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus
1996
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
2015
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Intrinsic Macrolide Resistance in Mycobacterium smegmatis Is Conferred by a Novel erm Gene, erm (38)
2003
Protein Radicals in Enzyme Catalysis
1998 Standout
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Synthesis of Proteins by Native Chemical Ligation
1994 StandoutScience
Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel
2008
Sepsis Syndrome, the Adult Respiratory Distress Syndrome, and Nosocomial Pneumonia
1990
Works of David E. Griffith being referenced
Mycobacterium abscessus . “Pleased to Meet You, Hope You Guess My Name..”
2015
Reduced Serum Levels Of Clarithromycin In Patients Treated With Multi-Drug Regimens Including Rifampin Or Rifabutin For Mycobacterium Avium-M. Intracellulare Infection
1995
Results of operation in Mycobacterium avium-intracellulare lung disease
1998
MYCOBACTERIA AS PATHOGENS OF RESPIRATORY INFECTION
1998
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
1994
Adverse Events Associated with High-Dose Rifabutin in Macrolide-Containing Regimens for the Treatment of Mycobacterium avium Complex Lung Disease
1995
The relationship between physicochemical properties, In vitro activity and pharmacokinetic profiles of analogues of diamine-Containing efflux pump inhibitors
2003
Initial (6-Month) Results of Three-Times-Weekly Azithromycin in Treatment Regimens for Mycobacterium avium Complex Lung Disease in Human Immunodeficiency Virus-Negative Patients
1998
Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease
2001
Relationship of Adverse Events to Serum Drug Levels in Patients Receiving High-Dose Azithromycin for Mycobacterial Lung Disease
1997
Clarithromycin-Associated Digoxin Toxicity in the Elderly
1997
Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus
1996
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
2014
Clinical Features of Pulmonary Disease Caused by Rapidly Growing Mycobacteria: An Analysis of 154 Patients
1993
Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials
2013
Early Results (at 6 Months) with Intermittent Clarithromycin-Including Regimens for Lung Disease Due to Mycobacterium avium Complex
2000
Repeat Positive Cultures inMycobacterium intracellulareLung Disease after Macrolide Therapy Represent New Infections in Patients with Nodular Bronchiectasis
2002
Hyperoxic Exposure in Humans
1992
Bronchiectasis and Nontuberculous Mycobacterial Disease
2012
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
1996
Cytokine Profiles in Immunocompetent Persons Infected withMycobacterium aviumComplex
2001
Elevated Levels of NAP-1/Interleukin-8 Are Present in the Airspaces of Patients with the Adult Respiratory Distress Syndrome and Are Associated with Increased Mortality
1992
Risk-Benefit Assessment of Therapies for Mycobacterium avium Complex Infections
1999
Thrice-Weekly Clarithromycin-Containing Regimen for Treatment of Mycobacterium kansasii Lung Disease: Results of a Preliminary Study
2003
Therapy of refractory nontuberculous mycobacterial lung disease
2012
Nontuberculous mycobacterial lung disease
2010
Pulmonary disease caused by rapidly growing mycobacteria
2002
Interleukin-1-mediated release of interleukin-8 by asbestos-stimulated human pleural mesothelial cells.
1994
Tuberculosis outbreak among healthcare workers in a community hospital.
1995
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
2014
Alveolar Macrophages from Patients with Asbestos Exposure Release Increased Levels of Leukotriene B 4
1989
Newly described or emerging human species of nontuberculous mycobacteria
2002
Contribution of Tissue Factor Associated with Factor VII
1987
Drug intolerance to high-dose clarithromycin among elderly patients
1993
Management of disease due to Mycobacterium kansasii
2002
Varying Dosages of Rifabutin Affect White Blood Cell and Platelet Counts in Human Immunodeficiency Virus-Negative Patients Who Are Receiving Multidrug Regimens for Pulmonary Mycobacterium avium Complex Disease
1996
Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa
2003
Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease
2006
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Ethambutol Ocular Toxicity in Treatment Regimens for Mycobacterium avium Complex Lung Disease
2005
Factors Related to Response to Intermittent Treatment of Mycobacterium avium Complex Lung Disease
2006
Polyclonal Mycobacterium avium Complex Infections in Patients with Nodular Bronchiectasis
1998
Clarithromycin-Induced Hepatotoxicity
1995
NOSOCOMIAL OUTBREAKS/PSEUDO OUTBREAKS CAUSED BY NONTUBERCULOUS MYCOBACTERIA
1998
Pulmonary Disease due to Rapidly Growing Mycobacteria
1988
Sensitivity of Fluorochrome Microscopy for Detection of Mycobacterium tuberculosis versus Nontuberculous Mycobacteria
1998
Differential effects of salmeterol on lung endothelial and epithelial leakage in sheep
1996
Vimentin Expressed onMycobacterium tuberculosis-Infected Human Monocytes Is Involved in Binding to the NKp46 Receptor
2006
T Cells Enhance Production of IL-18 by Monocytes in Response to an Intracellular Pathogen
2001
Pulmonary non-tuberculous mycobacterial infections.
2010
New developments in the treatment of nontuberculous mycobacterial (NTM) disease.
1996
Role of NK Cell-Activating Receptors and Their Ligands in the Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium
2005
Pulmonary Mycobacterial Disease
2004